Back to Journals » Drug Design, Development and Therapy

Drug Design, Development and Therapy

ISSN: 1177-8881


Editor-in-Chief: Prof. Dr. Frank Boeckler

An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal. 

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis

Shan M, Wan H, Ran L, Ye J, Xie W, Lu J, Hu X, Deng S, Zhang W, Chen M, Wang F, Guo Z

Drug Design, Development and Therapy 2024, 18:1369-1384

Published Date: 23 April 2024

Validation of Core Ingredients and Molecular Mechanism of Cinobufotalin Injection Against Liver Cancer

Chen S, Li M, Xue C, Zhou X, Wei J, Zheng L, Duan Y, Deng H, Tang F, Xiong W, Xiang B, Zhou M

Drug Design, Development and Therapy 2024, 18:1321-1338

Published Date: 23 April 2024

The Median Effective Dose of Intrathecal Hyperbaric Bupivacaine for Cesarean Section at Moderately High-Altitude

Yang C, Dong W, Luo J, Ma M, Gao Y, Ni L, Liu H, Cha C, Xiao Y, Huang S

Drug Design, Development and Therapy 2024, 18:1313-1319

Published Date: 22 April 2024

Natural and Synthetic Drugs Approached for the Treatment of Recurrent Aphthous Stomatitis Over the Last Decade

Vitamia C, Iftinan GN, Latarissa IR, Wilar G, Cahyanto A, Elamin KM, Wathoni N

Drug Design, Development and Therapy 2024, 18:1297-1312

Published Date: 22 April 2024


Read more articles